A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2004
10/20/2004	CN1171608C Capsule/medicament for treating rheumtism, rheumatoid archritis and its preparation method
10/20/2004	CN1171605C Pain-stopping bone-penetrating ointment and its prepn. preocess
10/20/2004	CN1171602C Plaster for treating fracture, soft tissue damage and bruise and its prepn. method
10/20/2004	CN1171599C Plaster for treating pain in neck, shoulder, waist and leg and its prepn process
10/20/2004	CN1171596C Exterally applied medcine powder for treating hyperosteogent in neck and waist
10/19/2004	US6806373 Dissolving leflunomide in a solvent to form a leflunomide solution, crystallizing leflunomide form iii from the leflunomide solution, and isolating leflunomide form iii, useful for the treatment of rheumatoid arthritis
10/19/2004	US6806370 NK-1 receptor active amine oxide prodrugs
10/19/2004	US6806312 Thermoplastic resin composition
10/19/2004	US6806274 Quinazoline derivatives
10/19/2004	US6806270 Selective antagonists of A2B adenosine receptors
10/19/2004	US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
10/19/2004	US6806252 Synergistic mixture of casein polypeptide to promote calcium absorption and genistein which inhibits bone resorption and promotes osteogenesis; prevent decrease in bone density and onset of osteoporosis
10/14/2004	WO2004087727A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
10/14/2004	WO2004087195A2 Therapeutic use of modulators of notch and/or kruppel-like factors
10/14/2004	WO2004087055A2 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
10/14/2004	WO2004071416A3 Novel inhibitors of formation of advanced glycation endproducts (ages)
10/14/2004	WO2004067550A3 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same
10/14/2004	WO2004043367A3 Fused heterocyclic compounds and use thereof
10/14/2004	WO2004029046A3 Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
10/14/2004	WO2004016769A3 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
10/14/2004	WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
10/14/2004	WO2003075945A3 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis
10/14/2004	WO2003065985A3 Uses of mammalian cytokine; related reagents
10/14/2004	WO2003031475A8 Antibodies against kdr, their production and uses
10/14/2004	US20040204596 preventing or treating degradation of collagen, degradation of collagen by bacterial collagenases during a bacterial infection, regeneration of skin and ligaments, tumoral invasion and degenerative diseases having fibrinoid degeneration of collagen
10/14/2004	US20040204590 Ep4 receptor agonist, compositions and methods thereof
10/14/2004	US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity
10/14/2004	US20040204467 Use of 5HT3-receptor-antagonists
10/14/2004	US20040204464 Isoxazoline compounds having MIF antagonist activity
10/14/2004	US20040204437 Substituted arylamine derivatives and methods of use
10/14/2004	US20040204432 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same
10/14/2004	US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease
10/14/2004	US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
10/14/2004	US20040204368 Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient
10/14/2004	US20040204345 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening
10/14/2004	US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene
10/14/2004	US20040203099 Conjugate of a transport protein and a protein for modulation of notch signalling
10/14/2004	US20040202736 Method of ameliorating side-effects of SERMs
10/14/2004	CA2520460A1 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
10/13/2004	EP1466925A1 Antibodies against fibroblast growth factor 23
10/13/2004	EP1466899A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
10/13/2004	EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004	EP1466631A1 Preparations appropriate for cartilage tissue formation
10/13/2004	EP1466624A1 Drug for regenerating tissue and vessel and method therefor
10/13/2004	EP1466623A1 Remedies for arthritis
10/13/2004	EP1466615A1 Pharmaceutical composition
10/13/2004	EP1466613A1 Compositions for mucosal and oral administration comprising hCG fragments
10/13/2004	EP1466609A1 Method of preparing and using isoflavones
10/13/2004	EP1466602A1 Organ fibrosis inhibitors
10/13/2004	EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy
10/13/2004	EP1465900A1 Rho-kinase inhibitors
10/13/2004	EP1465891A2 Inhibitors of dipeptidyl peptidase iv
10/13/2004	EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/13/2004	EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/13/2004	EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
10/13/2004	EP1465878A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
10/13/2004	EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
10/13/2004	EP1465854A2 Chalcone derivatives and their use to treat diseases
10/13/2004	EP1465659A2 Use of a novel cell surface protease from group b streptococcus
10/13/2004	EP1465649A2 Methods and compositions for derepression of iap-inhibited caspase
10/13/2004	EP1465638A2 Phosphate transport inhibitors
10/13/2004	EP1465631A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use
10/13/2004	EP1465623A1 Urea derivatives
10/13/2004	EP1465619A1 Suppression of cartilage degradation via the estrogen receptor
10/13/2004	EP1465614A2 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
10/13/2004	EP1465610A1 Use of a gsk-3beta inhibitor in the manufacture of a medicament for increasing bone formation
10/13/2004	EP1465606A2 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
10/13/2004	EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/13/2004	EP1322309A4 High affinity small molecule c5a receptor modulators
10/13/2004	EP1280820B1 Anti-inflammatory compounds and uses thereof
10/13/2004	EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/13/2004	EP1165533B1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/13/2004	CN1537105A Quinazolines as MMP-13 inhibitors
10/13/2004	CN1537101A Pyridine matrix metalloproteinase inhibitors
10/13/2004	CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives
10/13/2004	CN1537094A Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities
10/13/2004	CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc.
10/13/2004	CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor
10/13/2004	CN1537018A Therapeutic compositions for repairing chondropathy
10/13/2004	CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method
10/13/2004	CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases
10/13/2004	CN1537000A Novel imidazolidine derivatives, their preparation and their use as VLA-4 antagonists
10/13/2004	CN1535983A Blood vessel generating inhibitor
10/13/2004	CN1535969A Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application
10/13/2004	CN1535720A Medicine for curing severe and migratory arthralgia, its preparation method and application
10/13/2004	CN1535715A Medicine for external application for gout and its preparing method
10/13/2004	CN1535714A Medicine composition for preventing and curing osteoporosis and its preparation method
10/13/2004	CN1535704A Fresh Chinese medicine preparation for external application for mainly curing ankylosing spondylitis
10/13/2004	CN1535684A Aconitum kusnezoffii methylsine powder injection preparation and its preparation method
10/13/2004	CN1535683A Aconitum kusnezoffii methylsine aerosol and its preparation method
10/13/2004	CN1170849C Connective tissue growth factor fragments and methods and uses thereof
10/13/2004	CN1170826C Amide compounds
10/13/2004	CN1170583C Weilingxian wine
10/13/2004	CN1170580C Medicine for treating traumatic injury
10/13/2004	CN1170575C Exterio-applied medical wine for treating trauma
10/13/2004	CN1170561C Compound medicine for treating bony spur and its preparation technology
10/13/2004	CN1170538C Farnesyl protein transferase inhibitors for treating arthropathies
10/13/2004	CN1170527C Therapeutic perparation for inhalation containing parathyroid hormone, PTH
10/12/2004	USRE38624 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation
10/12/2004	US6803481 Treating different types and symptoms of acute and chronic pain, especially non neuropathic inflammatory pain in mammals. the pain to be treated may be e.g. chronic inflammatory pain, rheumatoid arthritis pain and/or secondary

1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 820